MET and glioblastoma: In conclusion, we reported here that erymet, a RBC‐encapsulated form of MGL, acted as an intravascular microbioreactor, and effectively led to a long‐term, sustained significant plasma Met depletion in vivo, resulting in an efficient tumor reduction growth in a GBM tumor‐bearing mouse model.